CHINA PHARMA HOLDINGS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
CHINA PHARMA HOLDINGS, INC. (CPHI) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $36.27 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-04-01
- CHINA PHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-09-30 was $15.24K.
- CHINA PHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $36.27K.
- CHINA PHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2011 was $76.99K, a 62.88% decline from fiscal 2010.
- CHINA PHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2010 was $207.42K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|
| 2022-12-31 | $36.27K 10-K · filed 2024-04-01 | |
| 2021-09-30 | $15.24K 10-Q · filed 2021-11-12 | |
| 2011-12-31 | $76.99K 10-K · filed 2012-03-14 | |
| 2010-12-31 | $207.42K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |